课题基金 / 基金详情

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease

Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
帕金森病基因修饰的机制分析
批准号:
10612362
负责人:
DIMITRI KRAINC
金额:
$120.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2029-04-30

项目摘要

项目成果

DIMITRI KRAINC的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary I believe that combining disease gene discovery approaches with in-depth follow-up mechanistic and functional studies is a unique aspect of my research program. Our recent discovery of “human-specific” pathways and phenotypes (compared to mice) in midbrain DA neurons has led us to focus on patient-derived DA neurons to examine the function of PD-linked genes. By employing co-cultures of iPS-derived neurons, microglia and astrocytes, we will examine the interplay of cell-autonomous and no-cell autonomous pathways that lead to dysfunction of midbrain DA neurons in PD. Moreover, we will use innovative technology to simultaneously examine a large number of genetic variants in a pooled iPS approach that has not been possible previously. Finally, our recent discovery of direct contacts between lysosomes and mitochondrial has opened a completely new opportunity to examine inter- and intra-organellar dynamics in neurodegeneration. The R35 award would provide me the time, freedom and stability to be even more adventurous and, as always, follow the most interesting biology to have a high impact on the field.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
Functional investigation of the role of TYR mutations and neuromelanin in Parkinson's disease
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein
海外基金